Kailera Therapeutics, Inc. Stocks - KLRA rate on the chart online today: price forecast, profitability, dividends, news, in guru portfolios – Oninvest

$ 11.71

Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only

Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only

Data is available to registered users only

Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts

Sign up to access all the key risk and return factors

In Guru Portfolios

Portfolio Weight (%)

Change

Fund

CITADEL ADVISORS LLC

Manager	Fund	Portfolio Weight (%)	Change
Kenneth Griffin	CITADEL ADVISORS LLC	0.0%	+0.01%

Risks

Default risk
Data is available to registered users only
Volatility
Data is available to registered users only
Selling difficulty
Data is available to registered users only
Stress test
Data is available to registered users only
Country risks
Data is available to registered users only
Other risks
Data is available to registered users only

Sign up to access detailed risk analysis

About

No company description

Undervalued

6/7

From both historical and forecast perspectives, the stock is underpriced compared to similar stocks.

Data is available to registered users only

Sign up to access detailed valuation

Risks

Default risk
Data is available to registered users only
Volatility
Data is available to registered users only
Selling difficulty
Data is available to registered users only
Stress test
Data is available to registered users only
Country risks
Data is available to registered users only
Other risks
Data is available to registered users only

Sign up to access detailed risk analysis